Valeant (VRX) August weekly volatility elevated as shares up in premarket on Q2 and outlook

Valeant Pharma (NYSE: VRX) is recently up $1.55 to $24 in the premarket on backs FY16 revenue guidance of $9.9B-$10.1B, compared to consensus $10.01B. August weekly call option implied volatility is at 147, August is at 109, September is at 84; compared to its 52-week range of 34 to 175.

You May Also Be Interested In

• On Holding AG (ONON) call put ratio 4.5 calls to 1 put with a focus on September 28 and 29 calls
• Mistras Group, Inc. (MG) call put ratio 36 calls to 1 put with a focus on October 22.5 and February 25 calls as share price up 3.2%
• SpaceX (SPCX) call put ratio 1 call to 1 put amid wide price movement